Showing results (61-70 of 357) with videos related to
Sort By:
Pageof 36
Journal of Medical Case Reports|July 29, 2016
Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reportsSarah A Milgrom, Yago Nieto, Chelsea C Pinnix, et al.Cancer|February 24, 2009
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemiaElias Jabbour, Sergio Giralt, Hagop Kantarjian, et al.Clinical Lymphoma, Myeloma & Leukemia|January 15, 2013
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicinPartow Kebriaei, Kaci Wilhelm, Farhad Ravandi, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2020
Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?Uri Greenbaum, Fevzi F Yalniz, Samer A Srour, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host diseasePartow Kebriaei, Luis Isola, Erkut Bahceci, et al.Journal of Hematology & Oncology|April 20, 2026
Uncoupling toxicity from efficacy in donor selection for allogeneic hematopoietic cell transplantation: a retrospective cohort study using double machine learningRohtesh S Mehta, Yosra M Aljawai, Warren Fingrut, et al.Transplantation and Cellular Therapy|June 9, 2024
Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three DecadesOren Pasvolsky, Curtis Marcoux, Jianliang Dai, et al.Transplantation and Cellular Therapy|May 18, 2025
Outcomes of Multiple Myeloma Patients With Prior Solid Tumors Undergoing Autologous TransplantationOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.Transplantation and Cellular Therapy|August 2, 2025
Outcomes of Patients With Multiple Myeloma With deletion 1p Following Autologous Stem Cell TransplantCurtis Marcoux, Denái R Milton, Mark R Tanner, et al.British Journal of Haematology|July 6, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myelomaCurtis Marcoux, Denái R Milton, Mark R Tanner, et al.Pageof 36